(Q39136059)

9 September 2017

title

Managing Cardiovascular Risk in Lysosomal Acid Lipase Deficiency (English)

1 reference

Erratum to: Managing Cardiovascular Risk in Lysosomal Acid Lipase Deficiency.

9 September 2017

corrigendum / erratum

0 references

author

James J Maciejko

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28197978%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

author name string

James J Maciejko

series ordinal

1

1 reference

9 September 2017

publication date

14 February 2017

1 reference

American journal of cardiovascular drugs

9 September 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28197978%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

volume

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28197978%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28197978%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

page(s)

217-231

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28197978%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s40256-017-0216-5

12 June 2020

exact match

0 references

cites work

Cholesteryl ester storage disease: review of the findings in 135 reported patients with an underdiagnosed disease

1 reference

https://api.crossref.org/works/10.1007%2FS40256-017-0216-5

SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40256-017-0216-5

Clinical Features of Lysosomal Acid Lipase Deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40256-017-0216-5

Exome sequencing and directed clinical phenotyping diagnose cholesterol ester storage disease presenting as autosomal recessive hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40256-017-0216-5

Lysosomal acid lipase deficiency--an under-recognized cause of dyslipidaemia and liver dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40256-017-0216-5

Genetic and biochemical evidence that CESD and Wolman disease are distinguished by residual lysosomal acid lipase activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40256-017-0216-5

Wolman's disease. A rare lipidosis with adrenal calcification

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40256-017-0216-5

Cholesteryl Ester Storage Disease (CESD) due to novel mutations in the LIPA gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40256-017-0216-5

Characterization of lysosomal acid lipase by site-directed mutagenesis and heterologous expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40256-017-0216-5

A splice junction mutation causes deletion of a 72-base exon from the mRNA for lysosomal acid lipase in a patient with cholesteryl ester storage disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40256-017-0216-5

Genomic organization of the human lysosomal acid lipase gene (LIPA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40256-017-0216-5

The Human Gene Mutation Database: 2008 update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40256-017-0216-5

Frequency of the cholesteryl ester storage disease common LIPA E8SJM mutation (c.894G>A) in various racial and ethnic groups.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40256-017-0216-5

Plasma PCSK9 preferentially reduces liver LDL receptors in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40256-017-0216-5

Lysosomal acid lipase deficiency impairs regulation of ABCA1 gene and formation of high density lipoproteins in cholesteryl ester storage disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40256-017-0216-5

Receptor-dependent hydrolysis of cholesteryl esters contained in plasma low density lipoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40256-017-0216-5

Suppression of apolipoprotein B production during treatment of cholesteryl ester storage disease with lovastatin. Implications for regulation of apolipoprotein B synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40256-017-0216-5

Hepatosplenomegalic lipidosis: what unless Gaucher? Adult cholesteryl ester storage disease (CESD) with anemia, mesenteric lipodystrophy, increased plasma chitotriosidase activity and a homozygous lysosomal acid lipase -1 exon 8 splice junction muta

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40256-017-0216-5

Enzyme deficiency in cholesteryl ester storage idisease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40256-017-0216-5

Cholesteryl ester storage disease: protean presentations of lysosomal acid lipase deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40256-017-0216-5

PCSK9: a convertase that coordinates LDL catabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40256-017-0216-5

Cholesterol ester storage disease (CESD) diagnosed in an asymptomatic adult

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40256-017-0216-5

Mechanisms of disease: genetic causes of familial hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40256-017-0216-5

National Lipid Association Annual Summary of Clinical Lipidology 2016.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40256-017-0216-5

Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40256-017-0216-5

Diagnosis of familial combined hyperlipidemia based on lipid phenotype expression in 32 families: results of a 5-year follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40256-017-0216-5

Evaluation of abnormal liver-enzyme results in asymptomatic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40256-017-0216-5

Thiadiazole carbamates: potent inhibitors of lysosomal acid lipase and potential Niemann-Pick type C disease therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40256-017-0216-5

A Phase 3 Trial of Sebelipase Alfa in Lysosomal Acid Lipase Deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40256-017-0216-5

Lysosomal acid lipase A and the hypercholesterolaemic phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40256-017-0216-5

Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174,000 participants in 27 randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40256-017-0216-5

Statins in the primary prevention of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40256-017-0216-5

Treatment of dyslipidemia with lovastatin and ezetimibe in an adolescent with cholesterol ester storage disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40256-017-0216-5

Lovastatin therapy for cholesterol ester storage disease in two sisters

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40256-017-0216-5

Wolman disease successfully treated by bone marrow transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40256-017-0216-5

Successful treatment of Wolman disease by unrelated umbilical cord blood transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40256-017-0216-5

Long-term metabolic, endocrine, and neuropsychological outcome of hematopoietic cell transplantation for Wolman disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40256-017-0216-5

Targeted disruption of the mouse lysosomal acid lipase gene: long-term survival with massive cholesteryl ester and triglyceride storage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40256-017-0216-5

Lysosomal enzymes and their receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40256-017-0216-5

Enzyme therapy for lysosomal acid lipase deficiency in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40256-017-0216-5

The role of mannosylated enzyme and the mannose receptor in enzyme replacement therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40256-017-0216-5

Wolman disease/cholesteryl ester storage disease: efficacy of plant-produced human lysosomal acid lipase in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40256-017-0216-5

Clinical effect and safety profile of recombinant human lysosomal acid lipase in patients with cholesteryl ester storage disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40256-017-0216-5

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40256-017-0216-5

2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40256-017-0216-5

Lipoprotein(a) and Family History of Cardiovascular Disease in Children with Familial Dyslipidemias

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40256-017-0216-5

10.1007/S40256-017-0216-5

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28197978%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

1 reference